Giving highest priority to ensure uninterrupted supply of medicines: Sharad Tyagi, Boehringer Ingelheim, India Read more
Govt initiatives lessen manufacturing and supply chain disruptions in Indian pharma industry: GlobalData Read more
Engaging with authorities to address challenges regarding manufacturing, distribution of drugs: OPPI Read more
COVID-19 lockdown affects pharma production in Uttarakhand as companies report low attendance Read more